ImmuCell Corporation Banner Image

ImmuCell Corporation

  • Ticker ICCC
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
ImmuCell Corporation Logo Image
  • 51-200 Employees
  • Based in Portland, Maine
ImmuCell Corporation's (Nasdaq: ICCC) purpose is to create scientifically-proven and practical products that improve the health and productivity of dairy and beef calves. ImmuCell manufactures and markets First Defense®, providing Immediate Immunity™ to newborn dairy and beef calves, and is in the late stages of developing Re-Tain™, a novel treatment for subclinical mastitis without a milkMore discard requirement that provides an alternative to traditional antibiotics.
4.8 / 5.0 (148)

ImmuCell Corporation reports have an aggregate usefulness score of 4.8 based on 148 reviews.

ImmuCell Corporation

Most Recent Annual Report

ImmuCell Corporation
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

ImmuCell Corporation Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!